[go: up one dir, main page]

FI921456L - Substituerade 2',3'-didesoxi-5-trifluormetyluridiner, foerfaranden foer deras framstaellning och deras anvaendning i laekemedel - Google Patents

Substituerade 2',3'-didesoxi-5-trifluormetyluridiner, foerfaranden foer deras framstaellning och deras anvaendning i laekemedel Download PDF

Info

Publication number
FI921456L
FI921456L FI921456A FI921456A FI921456L FI 921456 L FI921456 L FI 921456L FI 921456 A FI921456 A FI 921456A FI 921456 A FI921456 A FI 921456A FI 921456 L FI921456 L FI 921456L
Authority
FI
Finland
Prior art keywords
deras
trifluormethyluridiner
didesoxi
laekemedel
substituerade
Prior art date
Application number
FI921456A
Other languages
English (en)
Other versions
FI921456A7 (fi
FI921456A0 (fi
Inventor
Dieter Haebich
Rainer Neumann
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI921456A0 publication Critical patent/FI921456A0/fi
Publication of FI921456L publication Critical patent/FI921456L/fi
Publication of FI921456A7 publication Critical patent/FI921456A7/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/10Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI921456A 1991-04-05 1992-04-02 Substituoituja 2',3'-didesoksi-5-trifluorimetyyliuridiineja, menetelmiä niiden valmistamiseksi ja niiden käyttö lääkeaineissa FI921456A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4110977A DE4110977A1 (de) 1991-04-05 1991-04-05 Substituierte 2',3'-didesoxy-5-trifluormethyluridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Publications (3)

Publication Number Publication Date
FI921456A0 FI921456A0 (fi) 1992-04-02
FI921456L true FI921456L (fi) 1992-10-06
FI921456A7 FI921456A7 (fi) 1992-10-06

Family

ID=6428857

Family Applications (1)

Application Number Title Priority Date Filing Date
FI921456A FI921456A7 (fi) 1991-04-05 1992-04-02 Substituoituja 2',3'-didesoksi-5-trifluorimetyyliuridiineja, menetelmiä niiden valmistamiseksi ja niiden käyttö lääkeaineissa

Country Status (15)

Country Link
EP (1) EP0507188A1 (fi)
JP (1) JPH05148261A (fi)
KR (1) KR920019813A (fi)
CN (1) CN1065462A (fi)
AU (1) AU640860B2 (fi)
CA (1) CA2064916A1 (fi)
CS (1) CS92092A3 (fi)
DE (1) DE4110977A1 (fi)
FI (1) FI921456A7 (fi)
HU (1) HUT60748A (fi)
IE (1) IE921083A1 (fi)
IL (1) IL101482A0 (fi)
NO (1) NO921086L (fi)
NZ (1) NZ242205A (fi)
TW (1) TW205043B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1050846C (zh) * 1995-08-03 2000-03-29 中国医学科学院医药生物技术研究所 一种抗肿瘤抗生素云南霉素及其制备方法
AU2002257446A1 (en) * 2001-05-18 2002-12-03 Rakesh Kumar Antiviral nucleosides
CN100334100C (zh) * 2004-01-17 2007-08-29 杭州富邦生物制药有限公司 5-三氟甲基-2’-脱氧尿苷的合成方法
JP4603274B2 (ja) * 2004-02-24 2010-12-22 三井化学株式会社 2’−デオキシ−5−トリフルオロメチルウリジンの製造方法
WO2009119785A1 (ja) * 2008-03-28 2009-10-01 浜理薬品工業株式会社 エチニルチミジン化合物の精製方法
WO2009125841A1 (ja) * 2008-04-10 2009-10-15 浜理薬品工業株式会社 5-メチルウリジンを出発原料とするエチニルチミジン化合物の製造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3048877A1 (de) * 1980-12-23 1982-07-08 Kailash Kumar Prof. Dr. 2359 Lentföhrden Gauri Pyrimidinnucleosid-phosphonate, verfahren zur herstellung und sie enthaltende mittel
FI87783C (fi) * 1985-05-15 1993-02-25 Wellcome Found Foerfarande foer framstaellning av terapeutiskt anvaendbara 2',3'-dideoxinukleosider
DE3650741T2 (de) * 1985-09-17 2000-10-12 The Wellcome Foundation Ltd., Greenford Kombination therapeutische Nukleoside mit weiteren therapeutisch wirksamen Komponenten.
CA1327000C (en) * 1987-08-07 1994-02-15 David L.J. Tyrrell Antiviral therapy for hepatitis b
SE8704298D0 (sv) * 1987-11-03 1987-11-03 Astra Ab Compounds for use in therapy
US4900828A (en) * 1988-05-12 1990-02-13 Hoffmann-Laroche Inc. Intermediate compounds and an improved procedure for the synthesis of 2',3'-dideoxycytidine
SE8802173D0 (sv) * 1988-06-10 1988-06-10 Astra Ab Pyrimidine derivatives
GB8823320D0 (en) * 1988-10-05 1988-11-09 Nycomed As Chemical compounds
WO1990014079A1 (en) * 1989-05-15 1990-11-29 The United States Of America, Represented By The Secretary, United States Department Of Commerce Method of treatment of hepatitis
NZ234534A (en) * 1989-07-17 1994-12-22 Univ Birmingham Pyrimidine 4'-thionucleoside derivatives and their preparation; intermediates therefor

Also Published As

Publication number Publication date
AU1219092A (en) 1992-10-08
NO921086D0 (no) 1992-03-19
HUT60748A (en) 1992-10-28
NO921086L (no) 1992-10-06
DE4110977A1 (de) 1992-10-08
CA2064916A1 (en) 1992-10-06
IL101482A0 (en) 1992-12-30
JPH05148261A (ja) 1993-06-15
NZ242205A (en) 1993-04-28
CN1065462A (zh) 1992-10-21
CS92092A3 (en) 1992-12-16
FI921456A7 (fi) 1992-10-06
TW205043B (fi) 1993-05-01
FI921456A0 (fi) 1992-04-02
AU640860B2 (en) 1993-09-02
IE921083A1 (en) 1992-10-07
KR920019813A (ko) 1992-11-20
HU9201117D0 (en) 1992-06-29
EP0507188A1 (de) 1992-10-07

Similar Documents

Publication Publication Date Title
FI935795L (fi) Ctl4a-receptor, fusionsproteiner innehaollande denna och anvaendningar daerav
FI923337L (fi) Organiska fluorenylmetallfoereningar, framstaellning och anvaendning daerav
FI922977L (fi) Heterocykliska foereningar, deras framstaellning och anvaendning
FI923366L (fi) 5-lediga heterocykler, foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel
FI923960L (fi) 5-ledad heterocykler, foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel
FI921030L (fi) Cykliska ureaderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning
FI923691L (fi) Cykliska iminoderivat, dessa foereningar innehaollande farmaceutiska blandningar och foerfarande foer deras framstaellning
FI924687L (fi) Heterobiarylderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning
FI923223A7 (fi) Alkenylgrupper omfattande siloxankopolymerer, deras framstaellning och anvaendning
FI923775L (fi) 2-piperazinonfoereningar, deras framstaellning och anvaendning
FI934426L (fi) Tiazolidindionderivat, framstaellning och anvaendning daerav
FI931763L (fi) 4,1-bensoxazepinderivat och deras anvaendning
FI923947A7 (fi) Foerfarande foer pulsbreddsmodulation foer oekad linearitet, minskad kommutationsfoerlust och oekad utspaenning i en vaexelriktare/omriktare
FI924084L (fi) Tramadol-n-oxidmaterial, enantiomerer och kompositioner daerav och deras anvaendning
FI923143L (fi) Homogeniska, stabila och flytande vattenblandningar och anvaendning av naemnda blandningar foer framstaellning av dispersioner av i vatten oloesliga substanser
FI921049L (fi) Hydrazonderivat, deras framstaellning och anvaendning
FI920732L (fi) 2-substituerade kinoliner, foerfarande foer framstaellning av dessa och anvaendning av dessa i laekemedel
FI922875L (fi) Foereningar med reninhaemmande egenskaper, foerfarande foer deras framstaellning och deras anvaendning
FI925501L (fi) Imidazolfoereningar, deras framstaellning och anvaendning
FI922390L (fi) Initiatorsuspensioner, deras framstaellning och anvaendning
FI934680L (fi) Arylmorfolin, framstaellning och anvaending
FI923168L (fi) Sammansaettning haerstammande fraon baernstensglykan, framstaellningsfoerfarande och tillaempningar
FI922377L (fi) Glasblandning, daerav framstaellda glasfibrer och deras framstaellningsfoerfarande
FI923266A7 (fi) Faestprofil foer ramar foer vaeggelement, doerrar och foenster
FI924053L (fi) Substituerade aminopropaner, foerfarande foer deras framstaellning och deras anvaendning

Legal Events

Date Code Title Description
FD Application lapsed